The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | SHS | G01767105 | 439,452,000 | 14,040,000 | SH | SOLE | 14,040,000 | 0 | 0 | |||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 5,842,900 | 4,910,000 | SH | SOLE | 4,910,000 | 0 | 0 | |||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 5,456,000 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | |||
| BIOGEN INC | COM | 09062X103 | 183,158,550 | 643,000 | SH | SOLE | 643,000 | 0 | 0 | |||
| GILEAD SCIENCES INC | COM | 375558103 | 70,935,228 | 920,400 | SH | SOLE | 920,400 | 0 | 0 | |||
| INNOVIVA INC | COM | 45781M101 | 92,636,210 | 7,277,000 | SH | SOLE | 7,277,000 | 0 | 0 | |||
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 174,389,600 | 16,390,000 | SH | SOLE | 16,390,000 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 8,662,241 | 2,632,900 | SH | SOLE | 2,632,900 | 0 | 0 | |||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 21,811,590 | 231,300 | SH | SOLE | 231,300 | 0 | 0 | |||
| REGULUS THERAPEUTICS INC | COM | 75915K309 | 272,219 | 185,183 | SH | SOLE | 185,183 | 0 | 0 | |||
| VOR BIOPHARMA INC | COM | 929033108 | 1,909,620 | 618,000 | SH | SOLE | 618,000 | 0 | 0 | |||